Browse study websites

Discover. Prevent. Cure.

Menu Fundraise Donate

    Recommended pages

      Do you mean

        61-70 of 1538 results for 'grants'

        Refine search

        Individual Giving

        Your generosity creates a significant impact on our research and on the lives of children everywhere ...

        The Kerry M Stokes AC, Chair of Child Health

        This prestigious position, named in honour of Mr Kerry M Stokes AC and the enormous contribution he has made to child health research in Western ...

        Scientific Advisory Committee

        Chief Investigators Scientific Advisors Consumer Representatives Administration Officer Discover. Prevent. Cure. Stephen Stick Anthony Kicic Luke ...

        Research

        Effectiveness of 7-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Medically At-Risk Children in Australia: A Record Linkage Study

        Children with chronic medical conditions are at higher risk of invasive pneumococcal disease (IPD), but little is known about the effectiveness of the primary course of pneumococcal conjugate vaccine (PCV) in these children. ...

        Research

        Estimating pneumococcal vaccine coverage among Australian Indigenous children and children with medically at-risk conditions using record linkage

        Risk-based recommendations are common for pneumococcal vaccines but little is known about their uptake. In Australia, pneumococcal conjugate vaccine (PCV) was funded only for Aboriginal or Torres Strait Islander (Indigenous) children and those with underlying medical conditions in 2001, and then there were different booster dose recommendations depending on risk after the introduction of universal PCV vaccination in 2005. ...

        Research

        Mode of birth and risk of infection-related hospitalisation in childhood: A population cohort study of 7.17 million births from 4 high-income countries

        The proportion of births via cesarean section (CS) varies worldwide and in many countries exceeds WHO-recommended rates. Long-term health outcomes for children born by CS are poorly understood, but limited data suggest that CS is associated with increased infection-related hospitalisation. We investigated the relationship between mode of birth and childhood infection-related hospitalisation in high-income countries with varying CS rates. ...

        Research

        Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis

        Respiratory syncytial virus (RSV) is the most common cause of acute lower respiratory infection in young children. We previously estimated that in 2015, 33·1 million episodes of RSV-associated acute lower respiratory infection occurred in children aged 0-60 months, resulting in a total of 118 200 deaths worldwide. ...

        Research

        Modelled estimates of hospitalisations attributable to respiratory syncytial virus and influenza in Australia, 2009–2017

        Respiratory syncytial virus (RSV) and influenza are important causes of disease in children and adults. In Australia, information on the burden of RSV in adults is particularly limited. ...

        News & Events

        Telethon Kids Institute staff appointed to new Aboriginal research advisory committee

        Telethon Kids Institute has welcomed the establishment of an expert committee to guide decision-making around Aboriginal health and medical research in Western Australia. ...

        News & Events

        Diabetes Research WA Grant for Dr Mary Abraham

        WINNING DIABETES RESEARCH GRANTS UNVEILED Perth researchers have been awarded new West Australian funding to launch a pilot study into the use of ...

        Page 7 of 154